Boule Diagnostics Q3 sales fall on weak instrument demand
Boule Diagnostics Q3 sales fall on weak instrument demand
Overview
Sweden diagnostics supplier's Q3 sales fell 24% yr/yr due to sharp drop in instrument sales
Adjusted operating profit turned negative, mainly on lower sales
Recurring consumables and OEM sales remained stable, supporting gross margin
Outlook
Company says component shortages may continue to disrupt deliveries in Q4
Company evaluating options to strengthen financial position amid liquidity concerns
Company plans to focus on recurring business in reagents and OEM for stability
Result Drivers
COMPONENT SHORTAGES - Co said component shortages limited delivery capacity for key instrument lines, delaying order fulfillment
WEAK DEMAND - Co reported weak demand for 5-part human and veterinary instruments, citing restraint in several markets
MARKET RESTRICTIONS - Payment and currency flow restrictions in Middle East and Africa further affected sales, per co
Company press release: ID:nMFN5ZgNN6
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q3 Sales | Miss | SEK 96.20 mln | SEK 111 mln (1 Analyst) |
Q3 Adjusted Loss Per Share |
| SEK 0.06 |
|
Q3 Net Loss |
| SEK 2.50 mln |
|
Q3 Gross Margin |
| 41.10% |
|
Q3 Adjusted Free Cash Flow |
| SEK 6.90 mln |
|
Q3 Adjusted Operating Income |
| -SEK 4.50 mln |
|
Q3 Gross Profit |
| SEK 39.50 mln |
|
Q3 Operating Income |
| SEK 2.80 mln |
|
Analyst Coverage
The one available analyst rating on the shares is "hold"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."
Reuters Recommended Reads
Oct 22 - Sweden's Bonesupport Q3 revenue beats estimates on US segment growth
Oct 22 - Sweden's XVIVO Q3 revenue beat expectations on thoracic sales
Oct 21 - Sweden's Getinge Q3 organic sales rise 2.1%
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)